Abstract
17β-hydroxisteroid-dehydrogenase deficiency is a rare autosomal recessive form of male pseudohermaphroditism, due to mutations in the 17β-hydroxisteroid-dehydrogenase type 3 gene. Mutated genes encode an abnormal enzyme with absent or reduced ability to convert Δ 4-androstenedione to testosterone in the testis. Affected individuals are genetically males with normal male Wolffian structures, but have female external genitalia. These individuals are usually raised as females but undergo spontaneous virilization at puberty. Thus, correct diagnosis is mandatory to optimize treatment and follow-up. The clinical and laboratory approach as well as the follow-up of patients with male pseudohermaphroditism due to 17β-hydroxisteroid-dehydrogenase deficiency are detailed. The genetic mutations characterized to date are also summarized.
| Original language | English |
|---|---|
| Journal | Italian Journal of Pediatrics |
| Volume | 30 |
| Issue number | 1 |
| Pages (from-to) | 32-38 |
| Number of pages | 7 |
| ISSN | 1720-8424 |
| Publication status | Published - 02.2004 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
-
SDG 5 Gender Equality
-
SDG 10 Reduced Inequalities
Research Areas and Centers
- Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)
Fingerprint
Dive into the research topics of '17β-hydroxysteroid dehydrogenase-3 deficiency: Genetics, clinical findings, diagnosis and molecular biology'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver